Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
All Congress filingsSearch insider filingsEarnings calendarWatchlist
MORE TOOLS
Gold IntelligenceSilver IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeAll Congress filingsSearch insider filings
More research tools
ExploreGold IntelligenceSilver IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…

CongressSearchHomeWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
LOOK INSIDE THE BUSINESS

Company financials.

Explore company-wide revenue, income and balance-sheet facts directly from SEC filings.

View MBOT insider activity ↗

MBOTMicrobot Medical Inc.

THE LATEST REPORTED YEAR

The company reported a loss.

$13.14M net loss for the year ended December 31, 2025. These are reported results, not a forecast or a stock recommendation.

Revenue$116.89KYear ended December 31, 2015
Profit or loss-$13.14MYear ended December 31, 2025
Cash from the business-$13.05MYear ended December 31, 2025
Total assets$73.37MAs of June 30, 2026
Total liabilities$4.44MAs of June 30, 2026
Cash & equivalents$3.15MAs of June 30, 2026
THE BUSINESS BEHIND THE TICKER

Revenue, over time.

Latest-filed standard financial facts · USD

$992.87K
2009-12
$1.43M
2010-12
$1.22M
2011-12
$1.37M
2012-12
$172.3K
2013-12
$1.01M
2014-11
$116.89K
2015-12

Bars show magnitude; labels retain the sign. Each observation covers a reported annual period of 330–400 days; transition years can differ.

From the filing

Reported periods can differ from calendar years. Later filings may restate earlier figures. These are company-wide facts; product and geographic revenue segments are not included.

Reported periodReported valueFiledSource
January 1, 2015 – December 31, 2015$116,887March 15, 201610-K ↗
December 1, 2013 – November 30, 2014$1,012,391March 15, 201610-K ↗
January 1, 2013 – December 31, 2013$172,297March 15, 201610-K ↗
January 1, 2012 – December 31, 2012$1,367,955March 13, 201410-K ↗
January 1, 2011 – December 31, 2011$1,220,670March 13, 201410-K ↗
January 1, 2010 – December 31, 2010$1,426,972March 21, 201310-K ↗
January 1, 2009 – December 31, 2009$992,870March 15, 201210-K ↗
Source and calculation details

One standard US-GAAP or IFRS concept is selected per metric, using USD only. Annual durations must be 330–400 days. Quarterly durations must be 70–110 days; year-to-date totals are excluded, and fourth quarters are never inferred by subtraction. Cash-flow quarters can therefore be sparse. Conflicting values filed on the same day are excluded. Latest-filed values are used, so these observations must not be treated as facts known in an earlier backtest.

Concept: us-gaap:Revenues · Retrieved October 14, 2026

Response SHA-256: 5fc792c757c83821aa0cd636b3655419924829213ef914d8be1d9f56dce19054

SEC company facts

Company-wide USD figures from SEC filings. Each card keeps its own reporting date; later filings can revise earlier results.